课题基金 / 基金详情

ALZHEIMER'S DISEASE COOPERATIVE STUDY

ALZHEIMER'S DISEASE COOPERATIVE STUDY
阿尔茨海默病合作研究
批准号：
6278321
负责人：
Bruce Lee Miller
金额：
$3.92万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6278321
关键词：
Alzheimer's disease brain disorder chemotherapy clinical research cooperative study drug screening /evaluation human subject human therapy evaluation mental disorder chemotherapy mental health outcomes research pathologic process physical fitness prednisone

项目摘要

项目成果

Bruce Lee Miller的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To study the health status and thinking skills of patients with Alzheimer's disease. Also the tests that will be done are being assessed for their possible value in assessing patients with mental impairment. To see if prednisone, a corticosteroid, slows the rate of progression of Alzheimer's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RILUTEK IN SLOWING PROGRESSION OF FTD
UCLA ALZHEIMER'S DISEASE CENTER CORE GRANT
UCLA ALZHEIMER'S DISEASE CENTER CORE GRANT
UCLA ALZHEIMER'S DISEASE CENTER CORE GRANT